Initial Series A raise of $350 million funding Areteia Phase III development program of dexpramipexole in eosinophilic asthma, including three ongoing Phase III clinical trials Additional funding of $75 million will support significant expansion of the existing program, including adding … Continued
Yieldstreet is acquiring Cadre, a real estate investment platform with a mission to democratize access to investing, particularly in commercial real estate, Fortune is the first to report. Cadre’s founder and chief executive, Ryan Williams, will remain at the helm … Continued
(RTTNews) – Clinical-stage biopharmaceutical company Biohaven Ltd. (BHVN) Tuesday announced positive biomarker data from the Phase 1 electroencephalogram (EEG) biomarker study of its lead asset BHV-7000, proposed for the treatment of epilepsy. Examination of EEG in healthy subjects administered single … Continued
Through these collaborative efforts, SABIC aims to help reduce the carbon footprint in the agricultural supply chain, especially after the company obtained the world’s first independent certifications for low-carbon ammonia and blue hydrogen from TÜV Rheinland Group Riyadh: Agri-Nutrients SABIC, … Continued
In the EXHALE-1 study, dexpramipexole significantly reduced blood absolute eosinophil count (AEC) at week 12 versus placebo All three active doses achieved significance (150-mg, 75-mg, and 37.5-mg BID) Dexpramipexole displayed a favorable safety profile and was well tolerated, with 97% … Continued
Jul. 11, 2023, 07:00 AM Co-Founder Milind Mehere to transition to senior advisor and continue on Board of Directors Leadership Transition Comes as Yieldstreet Enters Next Phase of Growth NEW YORK, July 11, 2023 /PRNewswire/ — Yieldstreet (the “Company”), the … Continued
CHAPEL HILL, N.C.–(BUSINESS WIRE)–Areteia Therapeutics announced today that the first patients have been dosed in both the EXHALE-2 and EXHALE-4 trials as part of its overall Phase III clinical program investigating the efficacy and safety of oral dexpramipexole in severe … Continued
New WealthBridge platform makes adding alternative investments to retirement accounts as easy as buying a stock. NEW YORK, (BUSINESS WIRE) — Yieldstreet, the leading private market investing platform, and Equity Trust, one of the largest self-directed IRA custodians in the U.S., announced … Continued
ADM and BiOWiSH Technologies, Inc. (BiOWiSH) announced ADM will offer a BiOWiSH® Fertilizer Enhancement as an option to urea, monoammonium phosphate (MAP), diammonium phosphate (DAP) and NPK blends. The new product will be available from ADM Farm Direct Fertilizer as well … Continued
December 14, 2022 08:00 ET | Source: Third Pole Therapeutics Funding will support the final development phase prior to planned 2023 FDA submission of the company’s “breakthrough” designated eNOcare™ hospital device WALTHAM, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) — Third Pole … Continued
